-
1 Comment
Cachet Pharmaceutical Co., Ltd is currently in a long term downtrend where the price is trading 8.1% below its 200 day moving average.
From a valuation standpoint, the stock is 97.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.2.
Cachet Pharmaceutical Co., Ltd's total revenue rose by 9.2% to $7B since the same quarter in the previous year.
Its net income has dropped by 9.6% to $73M since the same quarter in the previous year.
Finally, its free cash flow grew by 484.4% to $535M since the same quarter in the previous year.
Based on the above factors, Cachet Pharmaceutical Co., Ltd gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| Industry | Pharmaceutical Retailers |
| Exchange | SHE |
| CurrencyCode | CNY |
| ISIN | CNE100000SN0 |
| Market Cap | 4B |
|---|---|
| PE Ratio | 14.88 |
| Target Price | 31.65 |
| Dividend Yield | 2.1% |
| Beta | 0.41 |
Cachet Pharmaceutical Co., Ltd. engages in the wholesale, retail, and logistics of pharmaceutical products in China. It also sells medical devices. Cachet Pharmaceutical Co., Ltd. is based in Beijing, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002462.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
